Back to search
FDAFDA · Food and drugs·Recall number D-0584-2016

Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.

Published January 27, 2016 · Recall initiated: November 4, 2015

Summary

FDA records drug Class II recall D-0584-2016, published January 27, 2016 and initiated November 4, 2015. Recalling firm: Pine Pharmaceuticals, LLC; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 1918@5, exp. 1/26/2016; 1820@5, exp. 1/12/2016; 1773@5, exp. 1/6/2016; 1665@5, exp. 12/22/2015; 1542@5, exp. 12/1/2015; 1544@6, exp. 12/1/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pine Pharmaceuticals, LLC
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 1918@5, exp. 1/26/2016; 1820@5, exp. 1/12/2016; 1773@5, exp. 1/6/2016; 1665@5, exp. 12/22/2015; 1542@5, exp. 12/1/2015; 1544@6, exp. 12/1/2015.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal injection, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150. recalled?

Yes. FDA published recall D-0584-2016 on January 27, 2016. Reported hazard: Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.

What should I do if I have this product?

Voluntary: Firm initiated · Letter